Please assess the completion status of the following clinical trial:

Trial Title: Comparing Two Medical Treatments for Early Pregnancy Failure.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Early pregnancy failure, 6-14 weeks postmenstrual with~* a crown-rump length ≥ 6mm and no cardiac activity OR~* a crown-rump length \<6mm and no fetal growth at least one week later OR~* a gestational sac with absent embryonic pole for at least one week.~  * At least one week after diagnosis OR a discrepancy of at least one week between crown-rump length and calendar gestational age~ * Intra-uterine pregnancy~ * Women aged above 16 years~ * Hemodynamic stable patient~ * No signs of infection~ * No signs of incomplete abortion~ * No contraindications for mifepristone or misoprostol~Exclusion Criteria:~* Patient does not meet inclusion criteria, discovered after randomization~* Inability to give informed consent~* Known clotting disorder or use of anticoagulants~* Known risk factors for, or presence of, a cardiovascular disease~* Language barrier

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Misoprostol (Type: PLACEBO_COMPARATOR): Before medical treatment with misoprostol (two doses 400mcg (four hours apart), repeated after 24 hours if no tissue is lost), patients receive an oral placebo.
- Misoprostol and Mifepristone (Type: EXPERIMENTAL): Before medical treatment with misoprostol (two doses 400mcg (four hours apart), repeated after 24 hours if no tissue is lost), patients receive oral mifepristone (600mg).

Based on this trial design, predict the completion outcome and termination type (if applicable).